Tirzepatide CAS 2023788-19-2 API
-
Price:
Negotiable
- minimum:
- Total supply:
-
Delivery term:
The date of payment from buyers deliver within days
-
seat:
Beijing
-
Validity to:
Long-term effective
-
Last update:
2024-09-26 22:36
-
Browse the number:
0
Company Profile
By certification [File Integrity]
Contact：okygikib(Mr.)
Email：
Telephone：
Phone：
Area：Beijing
Address：NO.288,Renyang, Binglun Village, Hushi Town, Xiuyu District, Putian City, Fujian Province 351146, China (CHN)
Website： http://8c2ce9c3.xjzcle.com/
Product Details
GIP is a hormone that may complement the effects of GLP-1 receptor agonists. In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids.link:http://www.genohopebio.com